A detailed history of Alhambra Investment Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alhambra Investment Partners LLC holds 7,251 shares of BMY stock, worth $415,699. This represents 0.2% of its overall portfolio holdings.

Number of Shares
7,251
Previous 8,813 17.72%
Holding current value
$415,699
Previous $366,000 2.46%
% of portfolio
0.2%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$39.66 - $51.75 $61,948 - $80,833
-1,562 Reduced 17.72%
7,251 $375,000
Q2 2024

Jul 15, 2024

SELL
$40.25 - $52.99 $369,293 - $486,183
-9,175 Reduced 51.01%
8,813 $366,000
Q1 2024

Apr 15, 2024

SELL
$47.98 - $54.4 $342,337 - $388,144
-7,135 Reduced 28.4%
17,988 $975,000
Q4 2023

Jan 17, 2024

SELL
$48.48 - $57.85 $18,810 - $22,445
-388 Reduced 1.52%
25,123 $1.29 Million
Q3 2023

Oct 17, 2023

BUY
$57.89 - $64.73 $23,213 - $25,956
401 Added 1.6%
25,511 $1.48 Million
Q2 2023

Jul 14, 2023

BUY
$63.71 - $70.74 $6,052 - $6,720
95 Added 0.38%
25,110 $1.61 Million
Q1 2023

Apr 18, 2023

BUY
$65.71 - $74.53 $49,348 - $55,972
751 Added 3.1%
25,015 $1.73 Million
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $58,550 - $69,331
-855 Reduced 3.4%
24,264 $0
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $56 - $33,579
437 Added 1.77%
25,119 $1.79 Million
Q2 2022

Jul 15, 2022

SELL
$72.62 - $79.98 $28,975 - $31,912
-399 Reduced 1.59%
24,682 $1.9 Million
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $54,778 - $65,684
-891 Reduced 3.43%
25,081 $1.83 Million
Q4 2021

Jan 21, 2022

BUY
$53.63 - $62.52 $120,613 - $140,607
2,249 Added 9.48%
25,972 $1.62 Million
Q3 2021

Oct 19, 2021

BUY
$59.17 - $69.31 $70,648 - $82,756
1,194 Added 5.3%
23,723 $1.4 Million
Q2 2021

Jul 15, 2021

BUY
$61.91 - $67.42 $37,455 - $40,789
605 Added 2.76%
22,529 $1.51 Million
Q1 2021

Apr 16, 2021

BUY
$59.34 - $66.74 $80,939 - $91,033
1,364 Added 6.63%
21,924 $1.38 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $21,075 - $23,881
365 Added 1.81%
20,560 $1.28 Million
Q3 2020

Nov 17, 2020

BUY
$57.43 - $63.64 $162,354 - $179,910
2,827 Added 16.28%
20,195 $1.22 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $13,595 - $15,894
-248 Reduced 1.41%
17,368 $1.02 Million
Q1 2020

Apr 30, 2020

SELL
$46.4 - $67.43 $40,646 - $59,068
-876 Reduced 4.74%
17,616 $982,000
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $909,991 - $1.19 Million
18,492 New
18,492 $1.19 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alhambra Investment Partners LLC Portfolio

Follow Alhambra Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alhambra Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alhambra Investment Partners LLC with notifications on news.